FDA posts nationwide recall of Blaine Labs wound care gels

The FDA has posted a nationwide recall of Blaine Labs wound care gels after testing found microbial contamination in the products.

The recall covers Revitaderm and Tridergel antiseptic wound care gel bottles and tubes. According to the FDA notice, the affected products were found to contain Lysinibacillus fusiformis, an environmental organism.

The notice says the products were distributed nationwide in the U.S. to healthcare providers, not through retail or internet sales. The recall applies to three lot numbers: BL3608, BL3435 and BL3525.

Blaine Labs said it had not received reports of adverse events at the time of the notice. The company’s recall announcement was dated April 7, 2026, and the FDA posted the alert on April 8.

The recall adds to a series of recent safety alerts affecting medical products used in clinical settings. For now, the key confirmed development is the FDA-posted nationwide recall and the affected lot list.